Profitelligence Profitelligence · Filing Ledger Open WST research →

Form 8-K · Current Report · Filed 2026-03-09

Eric M. Green Announces Retirement as CEO of West Pharmaceutical Services

West Pharmaceutical Services, Inc. announced that Eric M. Green, President, CEO, and Chair of the Board, intends to retire in the second half of 2026 after serving as CEO for 11 years. The Board is in the process of finding a successor through an executive recruiting firm. The company also reaffirmed its financial guidance for 2026, which was initially provided in the February 12, 2026 earnings release.

Filer
West Pharmaceutical Services Inc. WST · NYSE
Filed
Accession
0000105770-26-000041
CIK
0000105770
Signal
High impactHealthcare

Items reported

Item events

Reported Item

CEO Resignation General Statement

Market reaction

Close before filing

$245.86

Next session

-4.9%

Since filing

+38.7%

Latest close

$340.96

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from WST reporting the same item, with the next session's move:

About West Pharmaceutical Services Inc.

West Pharmaceutical Services Inc. is a leading global provider of innovative solutions for injectable drug administration. The company specializes in designing and manufacturing packaging and delivery systems specifically for pharmaceuticals, biologics, and vaccines. West Pharmaceutical Services plays a crucial role in ensuring the safety and efficiency of drug delivery through its products, which include stoppers, seals, containers, and pre-fillable syringe systems. Catering to a diverse range of healthcare and pharmaceutical clients, the company's offerings are integral in the development and distribution of injectable therapies across various therapeutic categories, including oncology, diabetes, and infectious diseases. As a partner to some of the world's leading pharmaceutical companies, West Pharmaceutical Services contributes significantly to advancements in medical treatments and healthcare technologies globally. Its commitment to quality and innovation underscores its importance in the pharmaceutical supply chain and enhances drug efficacy, ultimately impacting patient care and treatment outcomes.

Exchange NYSE Industry Medical Instruments & Supplies Company website ↗

Never miss another WST filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts